NCT01247597

DICER1-related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study

RecruitingOBSERVATIONAL

Trial Details

Start: 2011-02-13

Enrollment target: 1,500 participants

Locations

National Institutes of Health Clinical Center, Bethesda, Maryland, United States
National Cancer Institute - Shady Grove, Rockville, Maryland, United States

Contact

NCI Family Study Referralsncifamilystudyreferrals@mail.nih.gov (800) 518-8474

Douglas R Stewart, M.D.drstewart@mail.nih.gov (240) 276-7238

Other microbiome trials you might be interested in

Clinical Genetics Branch Eligibility Screening SurveyRecruiting

MelanomaLi-Fraumeni SyndromePulmonary BlastomaChordomaCongenital Bone Marrow Failure SyndromesCostello SyndromeFanconi AnemiaCFC Syndrome (CFCS)Legius SyndromeRASopathies

Background: Clinical Genetics Branch (CGB) researchers study individuals and populations at high genetic risk of cancer…

Rockville, United StatesEst. completion Jan 1, 2035

View Trial →

Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary BlastomaPhase 3Recruiting

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.